DAB2 and breast carcinoma: Methylation of the Dab2 promoter has previously been found to occur frequently in SCC27, lung29, nasopharyngeal30 and hepatocellular carcinoma31, while decreased Dab2 levels observed in breast cancer are not due to promoter methylation23.